United States - English - NLM (National Library of Medicine)

bryant ranch prepack - pregabalin (unii: 55jg375s6m) (pregabalin - unii:55jg375s6m) - pregabalin is indicated for: - management of neuropathic pain associated with diabetic peripheral neuropathy - management of postherpetic neuralgia - adjunctive therapy for the treatment of partial-onset seizures in patients 17 years of age and older - management of fibromyalgia - management of neuropathic pain associated with spinal cord injury pediatric use information is approved for pfizer’s lyrica (pregabalin) capsules and oral solution products. however, due to pfizer’s marketing exclusivity rights, this drug product is not labeled with that pediatric information.  pregabalin is contraindicated in patients with known hypersensitivity to pregabalin or any of its components. angioedema and hypersensitivity reactions have occurred in patients receiving pregabalin therapy [see warnings and precautions (5.2)]. pregnancy exposure registry there is a pregnancy exposure registry that monitors pregnancy outcomes in women exposed to pregabalin during pregnancy. to provide information regarding the effects of

United States - English - NLM (National Library of Medicine)

ascend laboratories, llc - pregabalin (unii: 55jg375s6m) (pregabalin - unii:55jg375s6m) - pregabalin is indicated for: - management of neuropathic pain associated with diabetic peripheral neuropathy - management of postherpetic neuralgia - adjunctive therapy for the treatment of partial-onset seizures in patients 17 years of age and older - management of fibromyalgia - management of neuropathic pain associated with spinal cord injury pediatric use information is approved for pfizer’s lyrica (pregabalin) capsules and oral solution products. however, due to pfizer’s marketing exclusivity rights, this drug product is not labeled with that pediatric information.  pregabalin is contraindicated in patients with known hypersensitivity to pregabalin or any of its components. angioedema and hypersensitivity reactions have occurred in patients receiving pregabalin therapy [see warnings and precautions (5.2)]. pregnancy exposure registry there is a pregnancy exposure registry that monitors pregnancy outcomes in women exposed to pregabalin during pregnancy. to provide information regarding the effects of

United States - English - NLM (National Library of Medicine)

proficient rx lp - pregabalin (unii: 55jg375s6m) (pregabalin - unii:55jg375s6m) - pregabalin capsules are indicated for: pregabalin capsules are contraindicated in patients with known hypersensitivity to pregabalin or any of its components. angioedema and hypersensitivity reactions have occurred in patients receiving pregabalin therapy [see warnings and precautions (5.2)]. pregnancy exposure registry there is a pregnancy exposure registry that monitors pregnancy outcomes in women exposed to pregabalin during pregnancy. to provide information regarding the effects of in utero exposure to pregabalin, physicians are advised to recommend that pregnant patients taking pregabalin enroll in the north american antiepileptic drug (naaed) pregnancy registry. this can be done by calling the toll free number 1-888-233-2334, and must be done by patients themselves. information on the registry can also be found at the website http://www.aedpregnancyregistry.org/. risk summary there are no adequate and well-controlled studies with pregabalin in pregnant women. however, in animal reproduction studies, in

United States - English - NLM (National Library of Medicine)

advanced rx pharmacy of tennessee, llc - pregabalin (unii: 55jg375s6m) (pregabalin - unii:55jg375s6m) - pregabalin is indicated for: • management of neuropathic pain associated with diabetic peripheral neuropathy • management of postherpetic neuralgia • adjunctive therapy for the treatment of partial-onset seizures in patients 17 years of age and older • management of fibromyalgia • management of neuropathic pain associated with spinal cord injury pediatric use information is approved for pfizer's lyrica (pregabalin) capsules and oral solution products. however, due to pfizer's marketing exclusivity rights, this drug product is not labeled with that pediatric information. pregabalin is contraindicated in patients with known hypersensitivity to pregabalin or any of its components. angioedema and hypersensitivity reactions have occurred in patients receiving pregabalin therapy [see warnings and precautions (5.2)]. 8.1 pregnancy pregnancy exposure registry there is a pregnancy exposure registry that monitors pregnancy outcomes in women exposed to pregabalin during pregnancy. to

United States - English - NLM (National Library of Medicine)

bryant ranch prepack - pregabalin (unii: 55jg375s6m) (pregabalin - unii:55jg375s6m) - pregabalin is indicated for:  • management of neuropathic pain associated with diabetic peripheral neuropathy  • management of postherpetic neuralgia  • adjunctive therapy for the treatment of partial-onset seizures in patients 17 years of age and older • management of fibromyalgia • management of neuropathic pain associated with spinal cord injury pediatric use information is approved for pfizer's lyrica (pregabalin) capsules and oral solution products. however, due to pfizer's marketing exclusivity rights, this drug product is not labeled with that pediatric information. pregabalin is contraindicated in patients with known hypersensitivity to pregabalin or any of its components. angioedema and hypersensitivity reactions have occurred in patients receiving pregabalin therapy [see warnings and precautions (5.2)].  pregnancy exposure registry there is a pregnancy exposure registry that monitors pregnancy outcomes in women exposed to pregabalin during pregnancy. to provide information re

United States - English - NLM (National Library of Medicine)

bryant ranch prepack - pregabalin (unii: 55jg375s6m) (pregabalin - unii:55jg375s6m) - pregabalin is indicated for:  • management of neuropathic pain associated with diabetic peripheral neuropathy  • management of postherpetic neuralgia  • adjunctive therapy for the treatment of partial-onset seizures in patients 17 years of age and older • management of fibromyalgia • management of neuropathic pain associated with spinal cord injury pediatric use information is approved for pfizer's lyrica (pregabalin) capsules and oral solution products. however, due to pfizer's marketing exclusivity rights, this drug product is not labeled with that pediatric information. pregabalin is contraindicated in patients with known hypersensitivity to pregabalin or any of its components. angioedema and hypersensitivity reactions have occurred in patients receiving pregabalin therapy [see warnings and precautions (5.2)].  pregnancy exposure registry there is a pregnancy exposure registry that monitors pregnancy outcomes in women exposed to pregabalin during pregnancy. to provide information re

United States - English - NLM (National Library of Medicine)

bryant ranch prepack - pregabalin (unii: 55jg375s6m) (pregabalin - unii:55jg375s6m) - pregabalin is indicated for:  • management of neuropathic pain associated with diabetic peripheral neuropathy  • management of postherpetic neuralgia  • adjunctive therapy for the treatment of partial-onset seizures in patients 17 years of age and older • management of fibromyalgia • management of neuropathic pain associated with spinal cord injury pediatric use information is approved for pfizer's lyrica (pregabalin) capsules and oral solution products. however, due to pfizer's marketing exclusivity rights, this drug product is not labeled with that pediatric information. pregabalin is contraindicated in patients with known hypersensitivity to pregabalin or any of its components. angioedema and hypersensitivity reactions have occurred in patients receiving pregabalin therapy [see warnings and precautions (5.2)].  pregnancy exposure registry there is a pregnancy exposure registry that monitors pregnancy outcomes in women exposed to pregabalin during pregnancy. to provide information re

United States - English - NLM (National Library of Medicine)

proficient rx lp - pregabalin (unii: 55jg375s6m) (pregabalin - unii:55jg375s6m) - pregabalin is indicated for:  • management of neuropathic pain associated with diabetic peripheral neuropathy  • management of postherpetic neuralgia  • adjunctive therapy for the treatment of partial-onset seizures in patients 17 years of age and older • management of fibromyalgia • management of neuropathic pain associated with spinal cord injury pediatric use information is approved for pfizer's lyrica (pregabalin) capsules and oral solution products. however, due to pfizer's marketing exclusivity rights, this drug product is not labeled with that pediatric information. pregabalin is contraindicated in patients with known hypersensitivity to pregabalin or any of its components. angioedema and hypersensitivity reactions have occurred in patients receiving pregabalin therapy [see warnings and precautions (5.2)].  pregnancy exposure registry there is a pregnancy exposure registry that monitors pregnancy outcomes in women exposed to pregabalin during pregnancy. to provide information r

United States - English - NLM (National Library of Medicine)

proficient rx lp - pregabalin (unii: 55jg375s6m) (pregabalin - unii:55jg375s6m) - pregabalin is indicated for:  • management of neuropathic pain associated with diabetic peripheral neuropathy  • management of postherpetic neuralgia  • adjunctive therapy for the treatment of partial-onset seizures in patients 17 years of age and older • management of fibromyalgia • management of neuropathic pain associated with spinal cord injury pediatric use information is approved for pfizer's lyrica (pregabalin) capsules and oral solution products. however, due to pfizer's marketing exclusivity rights, this drug product is not labeled with that pediatric information. pregabalin is contraindicated in patients with known hypersensitivity to pregabalin or any of its components. angioedema and hypersensitivity reactions have occurred in patients receiving pregabalin therapy [see warnings and precautions (5.2)].  pregnancy exposure registry there is a pregnancy exposure registry that monitors pregnancy outcomes in women exposed to pregabalin during pregnancy. to provide information r

United States - English - NLM (National Library of Medicine)

proficient rx lp - pregabalin (unii: 55jg375s6m) (pregabalin - unii:55jg375s6m) - pregabalin is indicated for:  • management of neuropathic pain associated with diabetic peripheral neuropathy  • management of postherpetic neuralgia  • adjunctive therapy for the treatment of partial-onset seizures in patients 17 years of age and older • management of fibromyalgia • management of neuropathic pain associated with spinal cord injury pediatric use information is approved for pfizer's lyrica (pregabalin) capsules and oral solution products. however, due to pfizer's marketing exclusivity rights, this drug product is not labeled with that pediatric information. pregabalin is contraindicated in patients with known hypersensitivity to pregabalin or any of its components. angioedema and hypersensitivity reactions have occurred in patients receiving pregabalin therapy [see warnings and precautions (5.2)].  pregnancy exposure registry there is a pregnancy exposure registry that monitors pregnancy outcomes in women exposed to pregabalin during pregnancy. to provide information r